Product logins

Find logins to all Clarivate products below.


Urological Devices | Market Insights | Europe | 2022

The deferral or cancellation of nonessential procedures due to the COVID-19 pandemic negatively impacted the European urological device market in 2020; however, the market will show a strong recovery in 2021. Following the short-term impact of the global pandemic, the market will continue to expand through 2030 due to growing patient awareness of urological treatments in this region. In particular, the rising use of minimally invasive laser treatments in Europe, where these techniques have been underpenetrated, will result in increased adoption of associated devices.

This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for urological devices in France, Germany, Italy, Spain, and the UK across an 11-year period.

Related Medtech Insights Reports

Report
Urological Devices – Market Insights – Europe
The European urological device market is set to grow through 2034, driven by product innovation, rising awareness, increasing kidney stone cases, and an aging population. Growth will be led by BPH…
Report
Gynecological Devices – Market Insights – Europe
The European gynecological device market will see marginal growth over the forecast period, fueled by the ongoing adoption of office-based treatments, the increasing preference for minimally…
Report
Interventional Oncology Devices – Market Insights – Europe
The European interventional oncology device market is projected to see modest growth through 2034, driven by rising cancer incidence and prevalence rates, updated clinical guidelines, and emerging…
Report
Gastrointestinal Endoscopy Devices – Market Insights – Europe
The European GI endoscopy device market will be primarily driven by the high incidence of gastric cancer and CRC cases in the region. Growth will be supported by nationwide CRC and GI cancer…
Report
Heart Valve Devices – Market Insights – Europe
The European heart valve device market will continue to observe moderate growth, particularly due to growing demand for minimally invasive cardiac interventions boosting the adoption of THV devices…